妊娠中期母体心血管功能与胎盘血管生成相关
前瞻性研究纳入4006例单胎妊娠孕妇,于19-23周测量血压、心率、胎盘生长因子(PlGF)、可溶性fms样酪氨酸激酶-1(sFlt-1)并行母体超声心动图。校正母体特征和妊娠并发症后,较低PlGF与较高平均动脉压、较低心率、较低二尖瓣s'平均速度和较大左房面积相关;sFlt-1与相对室壁厚度正相关,sFlt-1/PlGF比值与二尖瓣A负相关、与左房面积和平均动脉压正相关。结论认为胎盘功能受损似乎与轻度收缩和舒张功能障碍及心脏重构相关。
要点
- 妊娠中期较低PlGF与较高平均动脉压、较低心率和较大左房面积相关。
- sFlt-1/PlGF比值与左房面积和平均动脉压正相关,与二尖瓣A负相关。
- sFlt-1与相对室壁厚度正相关,提示胎盘血管生成与心脏重构相关。
核心结论
- 妊娠中期胎盘血管生成因子与亚临床母体心脏功能改变之间存在中等强度的连续关联,独立于既存母体危险因素和妊娠并发症。
研究设计与样本
- 前瞻性研究,纳入4006例单胎妊娠孕妇,于19-23周在英国伦敦国王学院医院常规就诊时测量母体特征、平均动脉压、心率、血清PlGF和sFlt-1,并行母体超声心动图评估心输出量、外周血管阻力及舒张和收缩功能指标。
诊断标准与关键数值
- 较低PlGF与较高平均动脉压相关(P < 0.0001)。
- 较低PlGF与较低母体心率相关(P < 0.0001)。
- 较低PlGF与较低二尖瓣s'平均速度相关(P = 0.027)。
- 较低PlGF与较高左房面积相关(P = 0.022)。
- sFlt-1与相对室壁厚度正相关(P = 0.012)。
临床应用与阅片要点
- 妊娠中期可结合PlGF、sFlt-1/PlGF比值与母体超声心动图指标评估亚临床心脏功能改变。
- sFlt-1/PlGF比值与二尖瓣A负相关(P = 0.006)、与左房面积正相关(P = 0.015)和平均动脉压正相关(P = 0.004)。
- 在无产科和内科危险因素的亚组中,上述关联强度相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether angiogenic markers of placental function are associated with maternal cardiac function and hemodynamic responses at 19-23 weeks' gestation, controlling for maternal risk factors and pregnancy complications.
METHODS: This was a prospective study of women with singleton pregnancy attending King's College Hospital, London, UK, for a routine hospital visit at 19-23 weeks' gestation. We recorded maternal characteristics and measured mean arterial pressure (MAP), maternal heart rate, serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1). We also performed maternal echocardiography to assess cardiac output and peripheral vascular resistance as well as indices of diastolic and systolic function.
RESULTS: Our cohort included 4006 women. Lower PlGF values were significantly associated with higher MAP (P < 0.0001), lower maternal heart rate (P < 0.0001), lower mitral valve s' mean velocity (P = 0.027) and higher left atrial area (P = 0.022) after adjustment for maternal characteristics and pregnancy complications. sFlt-1 was associated positively with relative wall thickness (P = 0.012), whereas sFlt-1/PlGF ratio was associated negatively with mitral valve A (P = 0.006) and positively with left atrial area (P = 0.015) and MAP (P = 0.004). The magnitude of these associations was similar in the subgroup of women without any risk factors based on their obstetric and medical history.
CONCLUSIONS: A continuous association of moderate strength between angiogenic factors and subclinical maternal cardiac function alterations is present in midgestation, independently of pre-existing maternal risk factors and pregnancy complications. Impaired placental function appears to be related to mild systolic and diastolic dysfunction and cardiac remodeling. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Papastefanou I, Szczepkowska A, Tezhaeva M, et al. Maternal cardiovascular function in midgestation is related to placental angiogenesis. Ultrasound Obstet Gynecol. 2024. PMID: 38354267. doi:10.1002/uog.27616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。